Kompleks Bölgesel Ağrı Sendromu ve Steroid Tedavisi

Yıl 2018, Cilt: 1 Sayı: 2, 77 - 82, 10.09.2018

Emel Güler

https://doi.org/10.33713/egetbd.440172

Öz

Kompleks
bölgesel ağrı sendromu (KBAS), klinik bulgularının günlük yaşam aktivitelerinde
kısıtlılığa neden olduğu, etkilenenen ekstremitede ağrı, distrofik ve sempatik
değişimlerin gözlendiği bir hastalıktır. Hastalığın tedavisindeki en önemli
basamak erken tanıdır. Tedavide ise multimodal yaklaşım tercih edilirken, bu
doğrultuda farmakolojik birçok ajan kullanılmakta ve bunlardan steroid,
antiinflamatuvar ve analjezik etkisi ile önemli bir yer tutmaktadır. Steroid
tedavisi ile ilgili yapılan birçok çalışma mevcutken, ilacın kullanım şekli,
miktarı ile ilgili bir standart oluşturulmamıştır. Bizim bu derlemede amacımız,
KBAS' da steroid tedavisinin etkinliği ve güvenilirliği ile ilgili çalışmaları
göstermekti.

Anahtar Kelimeler

Kompleks bölgesel ağrı sendromu, ağrı, steroid

Kaynakça

• Referans1 Atalay NS, Ercidogan O, Akkaya N, Sahin F: Prednisolone in complex regional pain syndrome. Pain Physician 2014, 17:179-85.
• Referans2 Kalita J, Misra U, Kumar A, Bhoi SK: Long-term prednisolone in post-stroke complex regional pain syndrome. Pain physician 2016, 19:565-74.
• Referans3 Shehab D, Elgazzar A, Collier BD, Naddaf S, Al-Jarallah K, Omar A, Al-Mutairy M: Impact of three-phase bone scintigraphy on the diagnosis and treatment of complex regional pain syndrome type I or reflex sympathetic dystrophy. Medical Principles and Practice 2006, 15:46-51.
• Referans4 Fischer SG, Zuurmond WW, Birklein F, Loer SA, Perez RS: Anti‐inflammatory treatment of Complex Regional Pain Syndrome. Pain 2010, 151:251-6.
• Referans5 Lee SK, Yang DS, Lee JW, Choy WS: Four treatment strategies for complex regional pain syndrome type 1. Orthopedics 2012, 35:e834-e42.
• Referans6 Eun Young H, Hyeyun K, Sang Hee I: Pamidronate effect compared with a steroid on complex regional pain syndrome type I: Pilot randomised trial. Neth J Med 2016, 74:30-5.
• Referans7 Kim YW, Kim Y, Kim JM, Hong JS, Lim HS, Kim HS: Is poststroke complex regional pain syndrome the combination of shoulder pain and soft tissue injury of the wrist?: A prospective observational study: STROBE of ultrasonographic findings in complex regional pain syndrome. Medicine (Baltimore) 2016, 95:e4388.
• Referans8 Ozturk E, Mohur H, Arslan N, Entok E, Tan K, Ozguven MA: Quantitative three-phase bone scintigraphy in the evaluation of intravenous regional blockade treatment in patients with stage-I reflex sympathetic dystrophy of upper extremity. Ann Nucl Med 2004, 18:653-8.
• Referans9 Varitimidis SE, Papatheodorou LK, Dailiana ZH, Poultsides L, Malizos KN: Complex regional pain syndrome type I as a consequence of trauma or surgery to upper extremity: management with intravenous regional anaesthesia, using lidocaine and methyloprednisolone. J Hand Surg Eur Vol 2011, 36:771-7.
• Referans10 Barbalinardo S, Loer SA, Goebel A, Perez RS: The Treatment of Longstanding Complex Regional Pain Syndrome with Oral Steroids. Pain Med 2016, 17:337-43.
• Referans11 Zyluk A, Puchalski P: Treatment of early complex regional pain syndrome type 1 by a combination of mannitol and dexamethasone. J Hand Surg Eur Vol 2008, 33:130-6.
• Referans12 askaynatan MA, Ozgul A, Tan AK, Dincer K, Kalyon TA: Bier block with methylprednisolone and lidocaine in CRPS type I: a randomized, double-blinded, placebo-controlled study. Reg Anesth Pain Med 2004, 29:408-12.
• Referans13 Kalita J, Vajpayee A, Misra UK: Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM 2006, 99:89-95.
• Referans14 Munts AG, van der Plas AA, Ferrari MD, Teepe-Twiss IM, Marinus J, van Hilten JJ: Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome. Eur J Pain 2010, 14:523-8.
• Referans15 Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M: Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain 2006, 22:235-9.
• Referans16 Klega A, Eberle T, Buchholz HG, Maus S, Maihofner C, Schreckenberger M, Birklein F: Central opioidergic neurotransmission in complex regional pain syndrome. Neurology 2010, 75:129-36.
• Referans17 Bank PJ, Peper CL, Marinus J, Beek PJ, van Hilten JJ: Motor dysfunction of complex regional pain syndrome is related to impaired central processing of proprioceptive information. J Pain 2013, 14:1460-74.
• Referans18 Brown S, Johnston B, Amaria K, Watkins J, Campbell F, Pehora C, McGrath P: A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand J Pain 2016, 13:156-63.
• Referans19 Rijsdijk M, van Wijck AJ, Kalkman CJ, Yaksh TL: The effects of glucocorticoids on neuropathic pain: a review with emphasis on intrathecal methylprednisolone acetate delivery. Anesth Analg 2014, 118:1097-112.
• Referans20 Deer TR, Levy RM, Kramer J, Poree L, Amirdelfan K, Grigsby E, Staats P, Burton AW, Burgher AH, Obray J, Scowcroft J, Golovac S, Kapural L, Paicius R, Kim C, Pope J, Yearwood T, Samuel S, McRoberts WP, Cassim H, Netherton M, Miller N, Schaufele M, Tavel E, Davis T, Davis K, Johnson L, Mekhail N: Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain 2017, 158:669-81.
• Referans21 Hardy RS, Zhou H, Seibel MJ, Cooper MS: Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy. Endocr Rev 2018.
• Referans22 Giusti A, Bianchi G: Treatment of complex regional pain syndrome type I with bisphosphonates. RMD Open 2015, 1:e000056.